| Literature DB >> 24784831 |
Marianna Virtanen1, Jane E Ferrie2, Adam G Tabak3, Tasnime N Akbaraly4, Jussi Vahtera5, Archana Singh-Manoux6, Mika Kivimäki7.
Abstract
OBJECTIVE: We examined whether psychological distress predicts incident type 2 diabetes and if the association differs between populations at higher or lower risk of type 2 diabetes. RESEARCH DESIGN AND METHODS: This was a prospective cohort of 5,932 diabetes-free adults (4,189 men and 1,743 women, mean age 54.6 years) with three 5-year data cycles (1991-2009): a total of 13,207 person-observations. Participants were classified into four groups according to their prediabetes status and Framingham Offspring Type 2 Diabetes Risk Score: normoglycemia with a risk score of 0-9, normoglycemia with a risk score of 10-19, prediabetes with a risk score of 10-19, and prediabetes with a risk score of >19. Psychological distress was assessed by the General Health Questionnaire. Incident type 2 diabetes was ascertained by 2-h oral glucose tolerance test, doctor diagnosis, or use of antihyperglycemic medication at the 5-year follow-up for each data cycle. Adjustments were made for age, sex, ethnicity, socioeconomic status, antidepressant use, smoking, and physical activity.Entities:
Mesh:
Year: 2014 PMID: 24784831 PMCID: PMC4113169 DOI: 10.2337/dc13-2725
Source DB: PubMed Journal: Diabetes Care ISSN: 0149-5992 Impact factor: 19.112
Figure 1Flowchart of the data cycles and sample selection procedure.
Characteristics of the participants at the baseline of the three cycles
| Baseline study cycle | ||||
|---|---|---|---|---|
| All | 1 (1991–1993)
| 2 (1997–1999)
| 3 (2002–2004)
| |
| Age, mean (SD) | 54.6 (7.7) | 49.2 (6.0) | 55.4 (5.9) | 60.6 (5.9) |
| Sex | ||||
| Male | 9,461 (71.6) | 3,788 (71.1) | 2,595 (71.4) | 3,078 (72.6) |
| Female | 3,746 (28.4) | 1,543 (28.9) | 1,040 (28.6) | 1,163 (27.4) |
| Ethnicity | ||||
| White | 12,325 (93.3) | 4,916 (92.2) | 3,412 (93.9) | 3,997 (94.3) |
| South Asian | 465 (3.5) | 210 (3.9) | 121 (3.3) | 134 (3.2) |
| Other | 417 (3.2) | 205 (3.9) | 102 (2.8) | 110 (2.6) |
| SES | ||||
| 1 highest | 5,476 (41.5) | 1,841 (34.5) | 1,626 (44.7) | 2,009 (47.4) |
| 2 | 6,120 (46.3) | 2,664 (50.0) | 1,610 (44.3) | 1,846 (43.5) |
| 3 lowest | 1,611 (12.2) | 826 (15.5) | 399 (11.0) | 386 (9.1) |
| Psychological distress | ||||
| No | 10,440 (79.1) | 4,173 (78.3) | 2,852 (78.5) | 3,415 (80.5) |
| Yes | 2,767 (21.0) | 1,158 (21.7) | 783 (21.5) | 826 (19.5) |
| Antidepressant use | ||||
| No | 12,905 (97.7) | 5,248 (98.4) | 3,549 (97.6) | 4,108 (96.9) |
| Yes | 302 (2.3) | 83 (1.6) | 86 (2.4) | 133 (3.1) |
| Smoking | ||||
| No | 11,992 (90.8) | 4,725 (88.6) | 3,315 (91.2) | 3,952 (93.2) |
| Yes | 1,215 (9.2) | 606 (11.4) | 320 (8.8) | 289 (6.8) |
| Physical activity | ||||
| High | 7,392 (56.0) | 2,839 (53.3) | 2,033 (55.9) | 2,520 (59.4) |
| Intermediate | 2,874 (21.8) | 1,542 (28.9) | 603 (16.6) | 729 (17.2) |
| Low | 2,941 (22.3) | 950 (17.8) | 999 (27.5) | 992 (23.4) |
| FRS, mean (SD) | 5.4 (5.3) | 5.0 (5.3) | 5.5 (5.4) | 5.8 (5.3) |
| Incidence of type 2 diabetes at follow-up | ||||
| No | 12,657 (95.8) | 5,155 (96.7) | 3,482 (95.8) | 4,020 (94.8) |
| Yes | 550 (4.2) | 176 (3.3) | 153 (4.2) | 221 (5.2) |
Figures are number (%) unless otherwise stated.
*Total N refers to the sum of participants (n of person-observations) in total and across the three study cycles (one participant can contribute to one or more study cycle); n in each study cycle refers to number of participants at that cycle.
Figure 2Unadjusted incidence (95% CI) of type 2 diabetes among participants with normoglycemia and participants with prediabetes; participants further stratified by the FRS and psychological distress.
Incidence of type 2 diabetes at follow-up among participants with normoglycemia and participants with prediabetes at baseline; participants further stratified by FRS and psychological distress
| Prediabetes status, risk level (FRS), and psychological distress at baseline | No. of person-observations | No. of incident cases | OR (95% CI) for incident type 2 diabetes | |||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Comparison 1 | Comparison 2 | Comparison 3 | Comparison 4 | Comparison 5 | Comparison 6 | Comparison 7 | Comparison 8 | |||
| All | 13,207 | 550 | ||||||||
| Normoglycemia, FRS 0–9, no distress | 8,025 | 129 | 1.00 (Ref.) | 0.83 (0.58–1.18) | 0.27 (0.19–0.36) | 0.21 (0.13–0.34) | 0.10 (0.08–0.13) | 0.09 (0.06–0.14) | 0.05 (0.03–0.06) | 0.02 (0.01–0.04) |
| Normoglycemia, FRS 0–9, distress | 2,220 | 41 | 1.20 (0.84–1.71) | 1.00 (Ref.) | 0.32 (0.21–0.48) | 0.25 (0.14–0.44) | 0.12 (0.09–0.18) | 0.11 (0.07–0.18) | 0.06 (0.04–0.08) | 0.03 (0.02–0.05) |
| Normoglycemia, FRS 10–19, no distress | 1,102 | 66 | 3.77 (2.76–5.14) | 3.13 (2.10–4.68) | 1.00 (Ref.) | 0.79 (0.47–1.33) | 0.38 (0.28–0.53) | 0.35 (0.23–0.56) | 0.18 (0.12–0.26) | 0.09 (0.05–0.15) |
| Normoglycemia, FRS 10–19, distress | 263 | 20 | 4.79 (2.93–7.84) | 3.98 (2.29–6.91) | 1.27 (0.75–2.15) | 1.00 (Ref.) | 0.49 (0.30–0.80) | 0.45 (0.25–0.81) | 0.22 (0.13–0.38) | 0.11 (0.05–0.21) |
| Prediabetes, FRS 10–19, no distress | 1,043 | 156 | 9.81 (7.60–12.66) | 8.15 (5.69–11.65) | 2.60 (1.90–3.56) | 2.05 (1.24–3.37) | 1.00 (Ref.) | 0.92 (0.61–1.40) | 0.46 (0.33–0.63) | 0.22 (0.13–0.37) |
| Prediabetes, FRS 10–19, distress | 218 | 34 | 10.64 (7.03–16.11) | 8.84 (5.45–14.33) | 2.82 (1.79–4.44) | 2.22 (1.23–4.01) | 1.09 (0.72–0.64) | 1.00 (Ref.) | 0.50 (0.32–0.78) | 0.24 (0.13–0.44) |
| Prediabetes, FRS >19, no distress | 270 | 77 | 21.39 (15.51–29.50) | 17.77 (11.84–26.69) | 5.68 (3.90–8.25) | 4.47 (2.62–7.61) | 2.18 (1.58–3.01) | 2.01 (1.28–3.17) | 1.00 (Ref.) | 0.48 (0.28–0.84) |
| Prediabetes, FRS >19, distress | 66 | 27 | 44.31 (26.29–74.68) | 36.81 (20.76–65.26) | 11.76 (6.77–20.42) | 9.25 (4.70–18.22) | 4.52 (2.67–7.63) | 4.16 (2.25–7.71) | 2.07 (1.19–3.62) | 1.00 (Ref.) |
Alternative reference groups are shown in comparisons 1–8. Models are adjusted for age, sex, SES, ethnicity, antidepressant use, smoking, and physical activity. All comparisons are based on the same data, but they have a different reference group. OR, odds ratio.